Back to Search

An Open-label, Multi-center, ph II Platform Study Evaluating the Efficacy and Safety of NIS793 and Other New Investigational Drug Combinations With SOC Anti-cancer Therapy for the 2L Treatment of Metastatic Colorectal Cancer (mCRC)

  • Protocol Number: 202205056
  • Principal Investigator: Pedersen, Katrina
  • Cancer Types: Gastrointestinal

For more information on this trial, contact us here:


Brief Summary

Protocol Interventions